Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis

Insulin resistance and nonalcoholic fatty liver disease have been linked to several lipid metabolites in animals, but their role in humans remains unclear. This study examined the relationship of sphingolipids with hepatic and peripheral metabolism in 21 insulin-resistant obese patients without (NAF...

Full description

Saved in:
Bibliographic Details
Published inDiabetes care Vol. 41; no. 6; pp. 1235 - 1243
Main Authors Apostolopoulou, Maria, Gordillo, Ruth, Koliaki, Chrysi, Gancheva, Sofia, Jelenik, Tomas, De Filippo, Elisabetta, Herder, Christian, Markgraf, Daniel, Jankowiak, Frank, Esposito, Irene, Schlensak, Matthias, Scherer, Philipp E., Roden, Michael
Format Journal Article
LanguageEnglish
Published United States American Diabetes Association 01.06.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Insulin resistance and nonalcoholic fatty liver disease have been linked to several lipid metabolites in animals, but their role in humans remains unclear. This study examined the relationship of sphingolipids with hepatic and peripheral metabolism in 21 insulin-resistant obese patients without (NAFL-) or with (NAFL+) nonalcoholic fatty liver and nonalcoholic steatohepatitis (NASH) and 7 healthy lean individuals undergoing tissue biopsies during bariatric or elective abdominal surgery. Hyperinsulinemic-euglycemic clamps with d-[6,6- H ]glucose were performed to quantify tissue-specific insulin sensitivity. Hepatic oxidative capacity, lipid peroxidation, and the phosphorylated-to-total c-Jun N-terminal kinase (pJNK-to-tJNK) ratio were measured to assess mitochondrial function, oxidative stress, and inflammatory activity. Hepatic total ceramides were higher by 50% and 33% in NASH compared with NAFL+ and NAFL-, respectively. Only in NASH were hepatic dihydroceramides (16:0, 22:0, and 24:1) and lactosylceramides increased. Serum total ceramides and dihydroceramides (hepatic dihydroceramides 22:0 and 24:1) correlated negatively with whole-body but not with hepatic insulin sensitivity. Hepatic maximal respiration related positively to serum lactosylceramide subspecies, hepatic sphinganine, and lactosylceramide 14:0. Liver lipid peroxides (total ceramides, sphingomyelin 22:0) and the pJNK-to-tJNK ratio (ceramide 24:0; hexosylceramides 22:0, 24:0, and 24:1) all positively correlated with the respective hepatic sphingolipids. Sphingolipid species are not only increased in insulin-resistant humans with NASH but also correlate with hepatic oxidative stress and inflammation, suggesting that these lipids may play a role during progression of simple steatosis to NASH in humans.
AbstractList Insulin resistance and nonalcoholic fatty liver disease have been linked to several lipid metabolites in animals, but their role in humans remains unclear. This study examined the relationship of sphingolipids with hepatic and peripheral metabolism in 21 insulin-resistant obese patients without (NAFL-) or with (NAFL+) nonalcoholic fatty liver and nonalcoholic steatohepatitis (NASH) and 7 healthy lean individuals undergoing tissue biopsies during bariatric or elective abdominal surgery.OBJECTIVEInsulin resistance and nonalcoholic fatty liver disease have been linked to several lipid metabolites in animals, but their role in humans remains unclear. This study examined the relationship of sphingolipids with hepatic and peripheral metabolism in 21 insulin-resistant obese patients without (NAFL-) or with (NAFL+) nonalcoholic fatty liver and nonalcoholic steatohepatitis (NASH) and 7 healthy lean individuals undergoing tissue biopsies during bariatric or elective abdominal surgery.Hyperinsulinemic-euglycemic clamps with d-[6,6-2H2]glucose were performed to quantify tissue-specific insulin sensitivity. Hepatic oxidative capacity, lipid peroxidation, and the phosphorylated-to-total c-Jun N-terminal kinase (pJNK-to-tJNK) ratio were measured to assess mitochondrial function, oxidative stress, and inflammatory activity.RESEARCH DESIGN AND METHODSHyperinsulinemic-euglycemic clamps with d-[6,6-2H2]glucose were performed to quantify tissue-specific insulin sensitivity. Hepatic oxidative capacity, lipid peroxidation, and the phosphorylated-to-total c-Jun N-terminal kinase (pJNK-to-tJNK) ratio were measured to assess mitochondrial function, oxidative stress, and inflammatory activity.Hepatic total ceramides were higher by 50% and 33% in NASH compared with NAFL+ and NAFL-, respectively. Only in NASH were hepatic dihydroceramides (16:0, 22:0, and 24:1) and lactosylceramides increased. Serum total ceramides and dihydroceramides (hepatic dihydroceramides 22:0 and 24:1) correlated negatively with whole-body but not with hepatic insulin sensitivity. Hepatic maximal respiration related positively to serum lactosylceramide subspecies, hepatic sphinganine, and lactosylceramide 14:0. Liver lipid peroxides (total ceramides, sphingomyelin 22:0) and the pJNK-to-tJNK ratio (ceramide 24:0; hexosylceramides 22:0, 24:0, and 24:1) all positively correlated with the respective hepatic sphingolipids.RESULTSHepatic total ceramides were higher by 50% and 33% in NASH compared with NAFL+ and NAFL-, respectively. Only in NASH were hepatic dihydroceramides (16:0, 22:0, and 24:1) and lactosylceramides increased. Serum total ceramides and dihydroceramides (hepatic dihydroceramides 22:0 and 24:1) correlated negatively with whole-body but not with hepatic insulin sensitivity. Hepatic maximal respiration related positively to serum lactosylceramide subspecies, hepatic sphinganine, and lactosylceramide 14:0. Liver lipid peroxides (total ceramides, sphingomyelin 22:0) and the pJNK-to-tJNK ratio (ceramide 24:0; hexosylceramides 22:0, 24:0, and 24:1) all positively correlated with the respective hepatic sphingolipids.Sphingolipid species are not only increased in insulin-resistant humans with NASH but also correlate with hepatic oxidative stress and inflammation, suggesting that these lipids may play a role during progression of simple steatosis to NASH in humans.CONCLUSIONSSphingolipid species are not only increased in insulin-resistant humans with NASH but also correlate with hepatic oxidative stress and inflammation, suggesting that these lipids may play a role during progression of simple steatosis to NASH in humans.
Insulin resistance and nonalcoholic fatty liver disease have been linked to several lipid metabolites in animals, but their role in humans remains unclear. This study examined the relationship of sphingolipids with hepatic and peripheral metabolism in 21 insulin-resistant obese patients without (NAFL-) or with (NAFL+) nonalcoholic fatty liver and nonalcoholic steatohepatitis (NASH) and 7 healthy lean individuals undergoing tissue biopsies during bariatric or elective abdominal surgery. Hyperinsulinemic-euglycemic clamps with d-[6,6- H ]glucose were performed to quantify tissue-specific insulin sensitivity. Hepatic oxidative capacity, lipid peroxidation, and the phosphorylated-to-total c-Jun N-terminal kinase (pJNK-to-tJNK) ratio were measured to assess mitochondrial function, oxidative stress, and inflammatory activity. Hepatic total ceramides were higher by 50% and 33% in NASH compared with NAFL+ and NAFL-, respectively. Only in NASH were hepatic dihydroceramides (16:0, 22:0, and 24:1) and lactosylceramides increased. Serum total ceramides and dihydroceramides (hepatic dihydroceramides 22:0 and 24:1) correlated negatively with whole-body but not with hepatic insulin sensitivity. Hepatic maximal respiration related positively to serum lactosylceramide subspecies, hepatic sphinganine, and lactosylceramide 14:0. Liver lipid peroxides (total ceramides, sphingomyelin 22:0) and the pJNK-to-tJNK ratio (ceramide 24:0; hexosylceramides 22:0, 24:0, and 24:1) all positively correlated with the respective hepatic sphingolipids. Sphingolipid species are not only increased in insulin-resistant humans with NASH but also correlate with hepatic oxidative stress and inflammation, suggesting that these lipids may play a role during progression of simple steatosis to NASH in humans.
OBJECTIVE Insulin resistance and nonalcoholic fatty liver disease have been linked to several lipid metabolites in animals, but their role in humans remains unclear. This study examined the relationship of sphingolipids with hepatic and peripheral metabolism in 21 insulin-resistant obese patients without (NAFL−) or with (NAFL+) nonalcoholic fatty liver and nonalcoholic steatohepatitis (NASH) and 7 healthy lean individuals undergoing tissue biopsies during bariatric or elective abdominal surgery. RESEARCH DESIGN AND METHODS Hyperinsulinemic-euglycemic clamps with d-[6,6-2H2]glucose were performed to quantify tissue-specific insulin sensitivity. Hepatic oxidative capacity, lipid peroxidation, and the phosphorylated-to-total c-Jun N-terminal kinase (pJNK-to-tJNK) ratio were measured to assess mitochondrial function, oxidative stress, and inflammatory activity. RESULTS Hepatic total ceramides were higher by 50% and 33% in NASH compared with NAFL+ and NAFL−, respectively. Only in NASH were hepatic dihydroceramides (16:0, 22:0, and 24:1) and lactosylceramides increased. Serum total ceramides and dihydroceramides (hepatic dihydroceramides 22:0 and 24:1) correlated negatively with whole-body but not with hepatic insulin sensitivity. Hepatic maximal respiration related positively to serum lactosylceramide subspecies, hepatic sphinganine, and lactosylceramide 14:0. Liver lipid peroxides (total ceramides, sphingomyelin 22:0) and the pJNK-to-tJNK ratio (ceramide 24:0; hexosylceramides 22:0, 24:0, and 24:1) all positively correlated with the respective hepatic sphingolipids. CONCLUSIONS Sphingolipid species are not only increased in insulin-resistant humans with NASH but also correlate with hepatic oxidative stress and inflammation, suggesting that these lipids may play a role during progression of simple steatosis to NASH in humans.
Author Gancheva, Sofia
Roden, Michael
Schlensak, Matthias
Esposito, Irene
Scherer, Philipp E.
Jelenik, Tomas
Markgraf, Daniel
Koliaki, Chrysi
De Filippo, Elisabetta
Jankowiak, Frank
Apostolopoulou, Maria
Gordillo, Ruth
Herder, Christian
Author_xml – sequence: 1
  givenname: Maria
  surname: Apostolopoulou
  fullname: Apostolopoulou, Maria
  organization: Division of Endocrinology and Diabetology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany, Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine University, Düsseldorf, Germany, German Center for Diabetes Research, München-Neuherberg, Germany
– sequence: 2
  givenname: Ruth
  surname: Gordillo
  fullname: Gordillo, Ruth
  organization: Touchstone Diabetes Center, Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX
– sequence: 3
  givenname: Chrysi
  surname: Koliaki
  fullname: Koliaki, Chrysi
  organization: Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine University, Düsseldorf, Germany, German Center for Diabetes Research, München-Neuherberg, Germany
– sequence: 4
  givenname: Sofia
  surname: Gancheva
  fullname: Gancheva, Sofia
  organization: Division of Endocrinology and Diabetology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany, Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine University, Düsseldorf, Germany, German Center for Diabetes Research, München-Neuherberg, Germany
– sequence: 5
  givenname: Tomas
  orcidid: 0000-0002-2061-1162
  surname: Jelenik
  fullname: Jelenik, Tomas
  organization: Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine University, Düsseldorf, Germany, German Center for Diabetes Research, München-Neuherberg, Germany
– sequence: 6
  givenname: Elisabetta
  surname: De Filippo
  fullname: De Filippo, Elisabetta
  organization: Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine University, Düsseldorf, Germany, German Center for Diabetes Research, München-Neuherberg, Germany
– sequence: 7
  givenname: Christian
  orcidid: 0000-0002-2050-093X
  surname: Herder
  fullname: Herder, Christian
  organization: Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine University, Düsseldorf, Germany, German Center for Diabetes Research, München-Neuherberg, Germany
– sequence: 8
  givenname: Daniel
  surname: Markgraf
  fullname: Markgraf, Daniel
  organization: Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine University, Düsseldorf, Germany, German Center for Diabetes Research, München-Neuherberg, Germany
– sequence: 9
  givenname: Frank
  surname: Jankowiak
  fullname: Jankowiak, Frank
  organization: Institute of Pathology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany
– sequence: 10
  givenname: Irene
  surname: Esposito
  fullname: Esposito, Irene
  organization: Institute of Pathology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany
– sequence: 11
  givenname: Matthias
  surname: Schlensak
  fullname: Schlensak, Matthias
  organization: General Surgery Department, Schön Clinic, Düsseldorf, Germany
– sequence: 12
  givenname: Philipp E.
  orcidid: 0000-0002-5336-1358
  surname: Scherer
  fullname: Scherer, Philipp E.
  organization: Touchstone Diabetes Center, Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX
– sequence: 13
  givenname: Michael
  orcidid: 0000-0001-8200-6382
  surname: Roden
  fullname: Roden, Michael
  organization: Division of Endocrinology and Diabetology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany, Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine University, Düsseldorf, Germany, German Center for Diabetes Research, München-Neuherberg, Germany
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29602794$$D View this record in MEDLINE/PubMed
BookMark eNpt0U1P3DAQBmCrWlQW2kP_AIrUS5EIjO14Ex_RigISAoltz5HjTLpeOXaInao98dfr8HVAPY1kP-9YnjkgC-cdEvKFwinjvDxrNS1zymn1gSyp5CIXoqgWZAm0kLmQku2TgxB2AFAUVfWR7DO5AlbKYkkeNwNq0xmdXeGgYqqbYWvcL2_NYNqQ3aNVEbPos2sXJmtcOgkmROU0nmR3f0ybQr8x28QRQzjJlGuT7Kzq-3ThXZYSt94pq_029UztI6rot0-PRRM-kb1O2YCfX-oh-fn94sf6Kr-5u7xen9_kmoOMOSpZVZUqWMPahqFU0DRtUwJ0WPGuKRsQvEAEVSKWjIJaIV0JFEy0mmuK_JB8e-47jP5hwhDr3gSN1iqHfgo1AwaFZELQRL--ozs_jekLs5KwYmViSR29qKnpsa2H0fRq_Fu_jjaB42egRx_CiN0boVDPa6vntdXz2pI9e2e1iU_zi6My9j-Jf-WKmwI
CitedBy_id crossref_primary_10_3390_nu12113240
crossref_primary_10_3390_foods11121747
crossref_primary_10_3390_membranes12040410
crossref_primary_10_1016_j_jhep_2020_11_030
crossref_primary_10_3390_life13041048
crossref_primary_10_3390_nu15143173
crossref_primary_10_1016_j_metabol_2024_155937
crossref_primary_10_1038_s41592_021_01198_0
crossref_primary_10_1152_physrev_00015_2017
crossref_primary_10_1186_s12944_020_01425_1
crossref_primary_10_1016_j_molmet_2020_101134
crossref_primary_10_3390_jcm11195613
crossref_primary_10_1007_s12072_019_09972_1
crossref_primary_10_1016_j_jlr_2025_100767
crossref_primary_10_3345_cep_2022_01312
crossref_primary_10_1016_j_tips_2021_10_001
crossref_primary_10_1111_dme_14494
crossref_primary_10_1016_j_fbio_2025_105861
crossref_primary_10_1016_j_isci_2024_111051
crossref_primary_10_1186_s12944_024_02380_x
crossref_primary_10_1016_j_cmet_2019_06_017
crossref_primary_10_1016_j_nano_2021_102430
crossref_primary_10_1210_endrev_bnae032
crossref_primary_10_1016_j_jhep_2021_04_013
crossref_primary_10_3390_atmos15010032
crossref_primary_10_1074_jbc_RA119_010393
crossref_primary_10_1016_j_jep_2024_118922
crossref_primary_10_1089_dna_2020_5402
crossref_primary_10_1021_acsomega_9b04402
crossref_primary_10_1111_liv_15575
crossref_primary_10_2337_dbi18_0018
crossref_primary_10_1016_j_apsb_2025_02_008
crossref_primary_10_1097_MPG_0000000000002875
crossref_primary_10_1152_ajpregu_00316_2021
crossref_primary_10_1002_hep_32778
crossref_primary_10_1016_j_metabol_2021_154892
crossref_primary_10_1016_j_biopha_2019_108868
crossref_primary_10_1016_j_tem_2022_08_001
crossref_primary_10_1007_s00125_020_05310_5
crossref_primary_10_1016_j_coph_2020_10_016
crossref_primary_10_1016_j_diabres_2024_111846
crossref_primary_10_1152_ajpgi_00186_2021
crossref_primary_10_32604_biocell_2024_048551
crossref_primary_10_1016_j_cmet_2022_09_022
crossref_primary_10_1007_s00216_021_03853_z
crossref_primary_10_1038_s42003_020_01513_z
crossref_primary_10_1007_s42995_023_00168_z
crossref_primary_10_1016_j_envint_2024_108820
crossref_primary_10_1016_j_lfs_2020_117678
crossref_primary_10_1016_j_envpol_2023_122238
crossref_primary_10_1016_j_jacl_2019_03_005
crossref_primary_10_3390_molecules27186117
crossref_primary_10_1038_s41467_020_16274_w
crossref_primary_10_1016_j_molmet_2020_101122
crossref_primary_10_15252_embr_202255664
crossref_primary_10_54005_geneltip_1415989
crossref_primary_10_3390_nu16203571
crossref_primary_10_1002_mnfr_202000034
crossref_primary_10_1152_ajpendo_00330_2020
crossref_primary_10_1038_s41366_023_01457_4
crossref_primary_10_1016_j_kint_2023_12_009
crossref_primary_10_1016_j_diabres_2022_109829
crossref_primary_10_2337_dc21_1758
crossref_primary_10_3389_fendo_2019_00665
crossref_primary_10_1039_D3FO00723E
crossref_primary_10_3390_md18060318
crossref_primary_10_3389_fendo_2021_684448
crossref_primary_10_1016_j_fbio_2024_105046
crossref_primary_10_3390_biology12040595
crossref_primary_10_3390_ijms232315442
crossref_primary_10_3390_nu15061359
crossref_primary_10_1111_apt_16066
crossref_primary_10_1016_j_xcrm_2020_100154
crossref_primary_10_2174_0113816128283153231226103218
crossref_primary_10_2174_1871520619666181224161255
crossref_primary_10_1016_j_ajcnut_2024_04_010
crossref_primary_10_1111_liv_14846
crossref_primary_10_1016_j_envint_2020_105880
crossref_primary_10_3389_fendo_2020_569250
crossref_primary_10_1016_j_ajpath_2019_09_011
crossref_primary_10_3748_wjg_v28_i43_6131
crossref_primary_10_1016_j_metabol_2020_154299
crossref_primary_10_3389_fcell_2019_00210
crossref_primary_10_2337_dc20_0329
crossref_primary_10_1016_j_biochi_2018_07_021
crossref_primary_10_3390_cells8030277
crossref_primary_10_2147_DDDT_S468147
crossref_primary_10_1152_ajpendo_00065_2019
crossref_primary_10_1007_s13534_024_00442_8
crossref_primary_10_1016_j_psj_2022_102428
crossref_primary_10_3748_wjg_v27_i25_3815
crossref_primary_10_1016_j_bbrc_2020_02_104
crossref_primary_10_1016_j_biopha_2021_112298
crossref_primary_10_1016_j_cmet_2021_12_012
crossref_primary_10_1371_journal_pone_0318557
crossref_primary_10_3390_metabo14010012
crossref_primary_10_1016_j_molmet_2022_101487
crossref_primary_10_1186_s12967_020_02296_x
crossref_primary_10_1002_jbt_23809
crossref_primary_10_3390_cells9051197
crossref_primary_10_1038_s41467_022_28496_1
crossref_primary_10_1016_j_metabol_2024_156063
crossref_primary_10_1016_j_heliyon_2024_e35491
crossref_primary_10_1007_s00018_022_04401_3
crossref_primary_10_1073_pnas_2007856117
crossref_primary_10_3390_jcm8122197
crossref_primary_10_1155_2020_3920196
crossref_primary_10_1016_j_bbrc_2019_08_111
crossref_primary_10_1038_s41591_019_0414_6
crossref_primary_10_1016_j_jep_2020_112999
crossref_primary_10_3390_molecules25184122
crossref_primary_10_1016_j_trsl_2020_07_008
crossref_primary_10_1016_j_jnutbio_2021_108808
crossref_primary_10_1038_s42255_019_0124_x
crossref_primary_10_1055_a_1417_5784
crossref_primary_10_1186_s41110_023_00206_x
crossref_primary_10_1016_j_jlr_2023_100366
crossref_primary_10_1016_j_xcrm_2024_101853
crossref_primary_10_1186_s43556_022_00088_x
crossref_primary_10_1186_s12933_023_01845_0
crossref_primary_10_58858_010102
crossref_primary_10_1038_s41575_021_00472_y
crossref_primary_10_3389_fnut_2024_1258570
crossref_primary_10_1080_01480545_2021_1962692
crossref_primary_10_3389_fendo_2020_00483
crossref_primary_10_1016_j_isci_2021_103549
crossref_primary_10_1371_journal_pone_0303296
crossref_primary_10_3390_nu16020274
crossref_primary_10_1111_obr_12820
crossref_primary_10_1016_j_jhep_2024_08_012
crossref_primary_10_3390_ijms241814015
crossref_primary_10_1111_1471_0528_17026
crossref_primary_10_1002_prp2_1094
crossref_primary_10_1055_s_0041_1732354
crossref_primary_10_3390_nu14112179
crossref_primary_10_1016_j_scitotenv_2024_178219
crossref_primary_10_1210_endocr_bqad084
crossref_primary_10_3389_fendo_2023_1193373
crossref_primary_10_1038_s41575_023_00888_8
crossref_primary_10_1038_s41598_022_11219_3
crossref_primary_10_1002_lipd_12244
crossref_primary_10_1111_liv_15059
crossref_primary_10_1111_dom_15466
crossref_primary_10_1016_j_jcyt_2021_12_009
crossref_primary_10_1038_s41586_019_1797_8
crossref_primary_10_1016_j_bcp_2022_115157
crossref_primary_10_1097_MED_0000000000000704
crossref_primary_10_2337_db19_0589
crossref_primary_10_1002_hep_31843
crossref_primary_10_1016_j_bbalip_2023_159318
crossref_primary_10_1136_bmjdrc_2020_001860
crossref_primary_10_1038_s41574_023_00898_1
crossref_primary_10_3390_ijms241612717
crossref_primary_10_1016_j_tem_2021_04_008
crossref_primary_10_1073_pnas_2117113119
crossref_primary_10_1210_er_2019_00034
crossref_primary_10_1038_s41575_020_00366_5
crossref_primary_10_1113_JP286955
crossref_primary_10_1194_jlr_M085613
crossref_primary_10_3390_metabo12100934
crossref_primary_10_1016_j_jhepr_2022_100479
crossref_primary_10_1038_s41575_021_00502_9
crossref_primary_10_1186_s12944_019_1114_4
crossref_primary_10_1042_BST20210508
crossref_primary_10_1016_j_jhep_2022_09_020
crossref_primary_10_3390_ijms22126332
crossref_primary_10_1016_j_molmet_2023_101851
crossref_primary_10_1126_science_aax6594
crossref_primary_10_1016_j_jep_2022_115427
crossref_primary_10_1111_fcp_12530
crossref_primary_10_1016_j_jdiacomp_2020_107734
crossref_primary_10_1210_jc_2019_00160
crossref_primary_10_1016_j_jlr_2024_100726
crossref_primary_10_1016_j_jhepr_2024_101185
crossref_primary_10_1016_j_jhep_2019_09_018
crossref_primary_10_1186_s12933_023_02049_2
crossref_primary_10_1249_MSS_0000000000003388
crossref_primary_10_3390_jcm10040792
crossref_primary_10_1038_s41575_021_00448_y
crossref_primary_10_1128_AAC_01755_20
crossref_primary_10_3390_jcm11051308
crossref_primary_10_1007_s10653_023_01794_3
crossref_primary_10_2337_dsi23_0013
crossref_primary_10_1530_JOE_19_0007
crossref_primary_10_1152_ajpcell_00123_2022
crossref_primary_10_1007_s00018_018_2984_8
crossref_primary_10_1111_eci_13695
crossref_primary_10_1002_mnfr_201900942
crossref_primary_10_1021_acsomega_2c00693
crossref_primary_10_1038_s41598_019_56715_1
crossref_primary_10_1111_obr_13248
crossref_primary_10_1038_s41401_019_0310_0
crossref_primary_10_1111_1753_0407_13120
crossref_primary_10_3390_cells9051106
crossref_primary_10_1016_j_prmcm_2021_100015
crossref_primary_10_3390_cancers15010023
crossref_primary_10_1016_S2213_8587_19_30076_2
crossref_primary_10_1053_j_gastro_2023_02_023
crossref_primary_10_3390_antiox11091727
crossref_primary_10_1038_s42255_021_00501_9
crossref_primary_10_3390_metabo11110779
crossref_primary_10_1053_j_gastro_2020_06_031
crossref_primary_10_1016_j_scitotenv_2020_143466
crossref_primary_10_1016_j_numecd_2023_06_004
crossref_primary_10_1139_cjpp_2019_0487
crossref_primary_10_1038_s41594_024_01414_3
crossref_primary_10_3389_fendo_2024_1400961
crossref_primary_10_1016_j_atherosclerosis_2020_08_006
crossref_primary_10_1007_s00125_018_4777_x
Cites_doi 10.1016/j.cmet.2011.11.004
10.2337/db08-1228
10.1073/pnas.1409229111
10.1038/nature21900
10.1038/nature13475
10.1194/jlr.M060061
10.1038/nm.2277
10.1210/me.2015-1069
10.1073/pnas.1113359108
10.1002/hep.23093
10.1038/nrgastro.2016.147
10.1007/s00125-009-1482-9
10.1096/fasebj.14.7.847
10.1016/S0168-8278(02)00073-9
10.1016/j.celrep.2017.05.035
10.2337/dc13-0382
10.1016/j.celrep.2017.02.019
10.1016/j.tem.2015.07.006
10.1007/s00125-016-4038-9
10.3748/wjg.v16.i42.5286
10.1053/j.gastro.2012.03.003
10.1007/s00216-011-4764-2
10.2337/db08-1074
10.1089/ars.2010.3815
10.1016/j.jhep.2016.01.002
10.1186/s12933-016-0374-9
10.1111/j.1440-1746.2010.06246.x
10.1016/j.cmet.2013.03.019
10.1016/j.cmet.2015.04.004
10.1152/ajpendo.00492.2015
10.1038/nrendo.2011.138
10.1016/j.biochi.2013.08.013
10.1111/j.1365-2036.2010.04405.x
10.2337/db13-1794
10.2337/db09-1293
10.1002/hep.20701
10.1002/dmrr.2662
ContentType Journal Article
Copyright 2018 by the American Diabetes Association.
Copyright American Diabetes Association Jun 1, 2018
Copyright_xml – notice: 2018 by the American Diabetes Association.
– notice: Copyright American Diabetes Association Jun 1, 2018
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
NAPCQ
7X8
DOI 10.2337/dc17-1318
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1935-5548
EndPage 1243
ExternalDocumentID 29602794
10_2337_dc17_1318
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-ET
..I
.XZ
08P
0R~
18M
29F
2WC
4.4
53G
5GY
5RE
5RS
5VS
6PF
8R4
8R5
AAFWJ
AAIKC
AAMNW
AAWTL
AAYEP
AAYXX
ABOCM
ABPPZ
ACGFO
ACGOD
ADBBV
AEGXH
AENEX
AERZD
AFOSN
AFRAH
AHMBA
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BENPR
BTFSW
CITATION
CS3
DIK
DU5
E3Z
EBS
EDB
EJD
EMOBN
EX3
F5P
GX1
H13
HZ~
IAO
IEA
IHR
INH
INR
IOF
IPO
KQ8
L7B
M0K
M5~
O5R
O5S
O9-
OK1
OVD
P2P
PCD
Q2X
RHI
SV3
TDI
TEORI
TR2
TWZ
VVN
W8F
WH7
WOQ
WOW
YHG
YOC
~KM
.55
.GJ
3O-
41~
7RV
7X2
7X7
88E
88I
8AF
8AO
8C1
8F7
8FE
8FH
8FI
8FJ
8G5
AAKAS
AAQOH
AAQQT
AAYJJ
ABUWG
ADZCM
AFFNX
AFKRA
AI.
AN0
AQUVI
ATCPS
AZQEC
BCR
BCU
BEC
BHPHI
BKEYQ
BKNYI
BLC
BNQBC
BPHCQ
BVXVI
C1A
CCPQU
CGR
CUY
CVF
DWQXO
ECM
EIF
FYUFA
GNUQQ
GUQSH
HCIFZ
HMCUK
IAG
ITC
J5H
K9-
M0R
M0T
M1P
M2O
M2P
M2Q
N4W
NAPCQ
NPM
PEA
PHGZT
PQQKQ
PROAC
PSQYO
S0X
SJFOW
UKHRP
VH1
WHG
X7M
ZCG
ZGI
ZXP
K9.
7X8
ID FETCH-LOGICAL-c309t-ea9888a42b2db2e9a0bbdb700fe83fb7b0534ee0a7ee7210a6e165e525dc3c1e3
ISSN 0149-5992
1935-5548
IngestDate Thu Jul 10 21:15:24 EDT 2025
Mon Jun 30 12:06:41 EDT 2025
Thu Apr 03 07:03:25 EDT 2025
Tue Jul 01 04:11:54 EDT 2025
Thu Apr 24 23:10:33 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License 2018 by the American Diabetes Association.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c309t-ea9888a42b2db2e9a0bbdb700fe83fb7b0534ee0a7ee7210a6e165e525dc3c1e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-5336-1358
0000-0002-2050-093X
0000-0001-8200-6382
0000-0002-2061-1162
PMID 29602794
PQID 2090627255
PQPubID 47715
PageCount 9
ParticipantIDs proquest_miscellaneous_2020492551
proquest_journals_2090627255
pubmed_primary_29602794
crossref_primary_10_2337_dc17_1318
crossref_citationtrail_10_2337_dc17_1318
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-06-01
PublicationDateYYYYMMDD 2018-06-01
PublicationDate_xml – month: 06
  year: 2018
  text: 2018-06-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Alexandria
PublicationTitle Diabetes care
PublicationTitleAlternate Diabetes Care
PublicationYear 2018
Publisher American Diabetes Association
Publisher_xml – name: American Diabetes Association
References Szendroedi (2022031301165910400_B3) 2014; 111
Luukkonen (2022031301165910400_B8) 2016; 64
Szendroedi (2022031301165910400_B9) 2011; 8
Wigger (2022031301165910400_B16) 2017; 18
Seki (2022031301165910400_B13) 2002; 37
Warshauer (2022031301165910400_B30) 2015; 31
Koliaki (2022031301165910400_B10) 2015; 21
Chaurasia (2022031301165910400_B2) 2015; 26
Gornicka (2022031301165910400_B12) 2011; 15
Herder (2022031301165910400_B23) 2013; 36
Xia (2022031301165910400_B29) 2014; 96
Novgorodov (2022031301165910400_B14) 2016; 57
Holland (2022031301165910400_B34) 2017; 544
Maceyka (2022031301165910400_B35) 2014; 510
Trevino (2022031301165910400_B27) 2015; 29
Haus (2022031301165910400_B36) 2009; 58
Lee (2022031301165910400_B37) 2010; 25
Kotronen (2022031301165910400_B7) 2009; 58
Gastaldelli (2022031301165910400_B33) 2010; 32
Jelenik (2022031301165910400_B22) 2014; 63
Ter Horst (2022031301165910400_B6) 2017; 19
Kuznetsov (2022031301165910400_B21) 2011; 400
García-Ruiz (2022031301165910400_B32) 2000; 14
Kleiner (2022031301165910400_B18) 2005; 41
Ussher (2022031301165910400_B28) 2010; 59
Magkos (2022031301165910400_B4) 2012; 142
Tilg (2022031301165910400_B1) 2017; 14
de Mello (2022031301165910400_B15) 2009; 52
Brunt (2022031301165910400_B17) 2010; 16
Szendroedi (2022031301165910400_B24) 2016; 15
Apostolopoulou (2022031301165910400_B19) 2016; 59
Holland (2022031301165910400_B25) 2013; 17
Holland (2022031301165910400_B26) 2011; 17
Patterson (2022031301165910400_B31) 2016; 310
Sunny (2022031301165910400_B11) 2011; 14
Szendroedi (2022031301165910400_B20) 2009; 50
Kumashiro (2022031301165910400_B5) 2011; 108
References_xml – volume: 14
  start-page: 804
  year: 2011
  ident: 2022031301165910400_B11
  article-title: Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2011.11.004
– volume: 58
  start-page: 337
  year: 2009
  ident: 2022031301165910400_B36
  article-title: Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance
  publication-title: Diabetes
  doi: 10.2337/db08-1228
– volume: 111
  start-page: 9597
  year: 2014
  ident: 2022031301165910400_B3
  article-title: Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1409229111
– volume: 544
  start-page: 42
  year: 2017
  ident: 2022031301165910400_B34
  article-title: Structural biology: receptors grease the metabolic wheels
  publication-title: Nature
  doi: 10.1038/nature21900
– volume: 510
  start-page: 58
  year: 2014
  ident: 2022031301165910400_B35
  article-title: Sphingolipid metabolites in inflammatory disease
  publication-title: Nature
  doi: 10.1038/nature13475
– volume: 57
  start-page: 546
  year: 2016
  ident: 2022031301165910400_B14
  article-title: Lactosylceramide contributes to mitochondrial dysfunction in diabetes
  publication-title: J Lipid Res
  doi: 10.1194/jlr.M060061
– volume: 17
  start-page: 55
  year: 2011
  ident: 2022031301165910400_B26
  article-title: Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
  publication-title: Nat Med
  doi: 10.1038/nm.2277
– volume: 29
  start-page: 1414
  year: 2015
  ident: 2022031301165910400_B27
  article-title: Liver perilipin 5 expression worsens hepatosteatosis but not insulin resistance in high fat-fed mice
  publication-title: Mol Endocrinol
  doi: 10.1210/me.2015-1069
– volume: 108
  start-page: 16381
  year: 2011
  ident: 2022031301165910400_B5
  article-title: Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1113359108
– volume: 50
  start-page: 1079
  year: 2009
  ident: 2022031301165910400_B20
  article-title: Abnormal hepatic energy homeostasis in type 2 diabetes
  publication-title: Hepatology
  doi: 10.1002/hep.23093
– volume: 14
  start-page: 32
  year: 2017
  ident: 2022031301165910400_B1
  article-title: NAFLD and diabetes mellitus
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2016.147
– volume: 52
  start-page: 2612
  year: 2009
  ident: 2022031301165910400_B15
  article-title: Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease
  publication-title: Diabetologia
  doi: 10.1007/s00125-009-1482-9
– volume: 14
  start-page: 847
  year: 2000
  ident: 2022031301165910400_B32
  article-title: Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release, and caspase activation
  publication-title: FASEB J
  doi: 10.1096/fasebj.14.7.847
– volume: 37
  start-page: 56
  year: 2002
  ident: 2022031301165910400_B13
  article-title: In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases
  publication-title: J Hepatol
  doi: 10.1016/S0168-8278(02)00073-9
– volume: 19
  start-page: 1997
  year: 2017
  ident: 2022031301165910400_B6
  article-title: Hepatic diacylglycerol-associated protein kinase Cε translocation links hepatic steatosis to hepatic insulin resistance in humans
  publication-title: Cell Reports
  doi: 10.1016/j.celrep.2017.05.035
– volume: 36
  start-page: 3663
  year: 2013
  ident: 2022031301165910400_B23
  article-title: Association of subclinical inflammation with polyneuropathy in the older population: KORA F4 study
  publication-title: Diabetes Care
  doi: 10.2337/dc13-0382
– volume: 18
  start-page: 2269
  year: 2017
  ident: 2022031301165910400_B16
  article-title: Plasma dihydroceramides are diabetes susceptibility biomarker candidates in mice and humans
  publication-title: Cell Reports
  doi: 10.1016/j.celrep.2017.02.019
– volume: 26
  start-page: 538
  year: 2015
  ident: 2022031301165910400_B2
  article-title: Ceramides—lipotoxic inducers of metabolic disorders [published correction appears in
  publication-title: Trends Endocrinol Metab
  doi: 10.1016/j.tem.2015.07.006
– volume: 59
  start-page: 2203
  year: 2016
  ident: 2022031301165910400_B19
  article-title: Metabolic flexibility and oxidative capacity independently associate with insulin sensitivity in individuals with newly diagnosed type 2 diabetes
  publication-title: Diabetologia
  doi: 10.1007/s00125-016-4038-9
– volume: 16
  start-page: 5286
  year: 2010
  ident: 2022031301165910400_B17
  article-title: Histopathology of nonalcoholic fatty liver disease
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v16.i42.5286
– volume: 142
  start-page: 1444
  year: 2012
  ident: 2022031301165910400_B4
  article-title: Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2012.03.003
– volume: 400
  start-page: 2383
  year: 2011
  ident: 2022031301165910400_B21
  article-title: Mitochondrial ROS production under cellular stress: comparison of different detection methods
  publication-title: Anal Bioanal Chem
  doi: 10.1007/s00216-011-4764-2
– volume: 58
  start-page: 203
  year: 2009
  ident: 2022031301165910400_B7
  article-title: Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver
  publication-title: Diabetes
  doi: 10.2337/db08-1074
– volume: 15
  start-page: 437
  year: 2011
  ident: 2022031301165910400_B12
  article-title: Transcriptional profile of genes involved in oxidative stress and antioxidant defense in a dietary murine model of steatohepatitis
  publication-title: Antioxid Redox Signal
  doi: 10.1089/ars.2010.3815
– volume: 64
  start-page: 1167
  year: 2016
  ident: 2022031301165910400_B8
  article-title: Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2016.01.002
– volume: 15
  start-page: 59
  year: 2016
  ident: 2022031301165910400_B24
  article-title: Cohort profile: the German Diabetes Study (GDS)
  publication-title: Cardiovasc Diabetol
  doi: 10.1186/s12933-016-0374-9
– volume: 25
  start-page: 1105
  year: 2010
  ident: 2022031301165910400_B37
  article-title: Effects of sphingolipid synthesis inhibition on cholesterol gallstone formation in C57BL/6J mice
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2010.06246.x
– volume: 17
  start-page: 790
  year: 2013
  ident: 2022031301165910400_B25
  article-title: An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2013.03.019
– volume: 21
  start-page: 739
  year: 2015
  ident: 2022031301165910400_B10
  article-title: Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2015.04.004
– volume: 310
  start-page: E484
  year: 2016
  ident: 2022031301165910400_B31
  article-title: Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00492.2015
– volume: 8
  start-page: 92
  year: 2011
  ident: 2022031301165910400_B9
  article-title: The role of mitochondria in insulin resistance and type 2 diabetes mellitus
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/nrendo.2011.138
– volume: 96
  start-page: 130
  year: 2014
  ident: 2022031301165910400_B29
  article-title: The adipokine/ceramide axis: key aspects of insulin sensitization
  publication-title: Biochimie
  doi: 10.1016/j.biochi.2013.08.013
– volume: 32
  start-page: 769
  year: 2010
  ident: 2022031301165910400_B33
  article-title: Pioglitazone in the treatment of NASH: the role of adiponectin
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/j.1365-2036.2010.04405.x
– volume: 63
  start-page: 3856
  year: 2014
  ident: 2022031301165910400_B22
  article-title: Tissue-specific differences in the development of insulin resistance in a mouse model for type 1 diabetes
  publication-title: Diabetes
  doi: 10.2337/db13-1794
– volume: 59
  start-page: 2453
  year: 2010
  ident: 2022031301165910400_B28
  article-title: Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption
  publication-title: Diabetes
  doi: 10.2337/db09-1293
– volume: 41
  start-page: 1313
  year: 2005
  ident: 2022031301165910400_B18
  article-title: Design and validation of a histological scoring system for nonalcoholic fatty liver disease
  publication-title: Hepatology
  doi: 10.1002/hep.20701
– volume: 31
  start-page: 734
  year: 2015
  ident: 2022031301165910400_B30
  article-title: Effect of pioglitazone on plasma ceramides in adults with metabolic syndrome
  publication-title: Diabetes Metab Res Rev
  doi: 10.1002/dmrr.2662
SSID ssj0004488
Score 2.628325
Snippet Insulin resistance and nonalcoholic fatty liver disease have been linked to several lipid metabolites in animals, but their role in humans remains unclear....
OBJECTIVE Insulin resistance and nonalcoholic fatty liver disease have been linked to several lipid metabolites in animals, but their role in humans remains...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 1235
SubjectTerms Abdominal surgery
Adult
Animals
c-Jun protein
Ceramide
Clamps
Correlation
Disease Progression
Fatty liver
Female
Glucose Clamp Technique
Humans
Inflammation
Inflammation - blood
Inflammation - metabolism
Inflammation - physiopathology
Insulin
Insulin resistance
Insulin Resistance - physiology
JNK protein
Lipid metabolism
Lipid peroxidation
Lipid Peroxidation - physiology
Lipids
Liver
Liver - chemistry
Liver - metabolism
Liver - pathology
Liver diseases
Male
Metabolism
Metabolites
Middle Aged
Mitochondria
Non-alcoholic Fatty Liver Disease - blood
Non-alcoholic Fatty Liver Disease - metabolism
Non-alcoholic Fatty Liver Disease - physiopathology
Obesity - blood
Obesity - metabolism
Obesity - physiopathology
Obesity - surgery
Oxidation resistance
Oxidation-Reduction
Oxidative stress
Oxidative Stress - physiology
Peroxidation
Peroxides
Prospective Studies
Research design
Sensitivity
Sphinganine
Sphingolipids
Sphingolipids - analysis
Sphingolipids - blood
Sphingolipids - metabolism
Sphingomyelin
Steatosis
Surgery
Transcription factors
Title Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis
URI https://www.ncbi.nlm.nih.gov/pubmed/29602794
https://www.proquest.com/docview/2090627255
https://www.proquest.com/docview/2020492551
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKkBAviG8KAxnEAw8LJE7SJI_TxmgZKx_dpL1FduyokaqkWlOEeOEf4I_mzna8dCoIeImq1LEt3y_nO-fud4S8zMJRIgLGPRkz6UWRjD2hSuEFKowKJZM45pgofDIdjc-i9-fx-WDwsxe1tG7F6-L71ryS_5Eq3AO5YpbsP0jWdQo34DfIF64gYbj-lYx18fiyKmDzWGrm1dkSD5SaRbWs5MoEuunSGBMbcf5FrdBerM3J-cdvlTS83zOdMdJFck7qEnBichrxPGSK1rqupItDtOinz_WAbbXqG7eH3TkuhpM5JC2RumPRLJv1olnb9KDKbQbvwPmt7PcfjLZ3GwAMxk1J7YP5BWDJPQCzn6uv2uadwerx_rlFkF7GV_VSBUCHubldxWN34Jl5cZZtaGxDlWWR2Ve_mPi7bV9goWYWkAVsyUFoFf4G9_Z4f5Z_OjzKP0ymx9fIdQZOB9bDOP7c456PdBVTNyPDU4Vdv3Edb1o3v3FZtOlyepvcsj4H3TcAukMGqr5LbpzYqIp75EeHI2pxRDdwRA2OaNtQiyN6iaM96lBEDYr2KGCI9jFE4Yk-hugVDN0nZ0dvTw_Gni3M4RWhn7We4lmapjxigknBVMZ9IaRIfL9UaViKRIBmj5TyeaJUwgKfj1QwilXMYlmEBaiBB2Snbmr1iFCRId9QIjOsdBAkJS9gQXnqcylEXKZqSF51C5oXlrUei6cscvBece1zXPsc135IXrimS0PVsq3RbieV3L7Jq5z5mq0bvOshee7-Bj2LH894rZo1tmE-EnnGwZA8NNJ0o7Bs5DOY_-M_d_6E3OxehNDfJTvtxVo9BZO2Fc800n4B_1SqsA
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Specific+Hepatic+Sphingolipids+Relate+to+Insulin+Resistance%2C+Oxidative+Stress%2C+and+Inflammation+in+Nonalcoholic+Steatohepatitis&rft.jtitle=Diabetes+care&rft.au=Apostolopoulou%2C+Maria&rft.au=Gordillo%2C+Ruth&rft.au=Koliaki%2C+Chrysi&rft.au=Gancheva%2C+Sofia&rft.date=2018-06-01&rft.pub=American+Diabetes+Association&rft.issn=0149-5992&rft.volume=41&rft.issue=6&rft.spage=1235&rft_id=info:doi/10.2337%2Fdc17-1318&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0149-5992&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0149-5992&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0149-5992&client=summon